Malignancy-related hypercalcemia in the bisphosphonate era

被引：0
|
作者：
Alves, M. F. S. [1 ]
Mak, M. P. [1 ]
Piotto, G. H. M. [1 ]
Takahashi, T. K. [1 ]
Ramos, R. E. O. [1 ]
Fonseca, L. G. [1 ]
Silvino, M. [1 ]
Mano, M. S. [1 ]
Hoff, P. M. [1 ]
Castro, G., Jr. [1 ]
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1368
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [21] ASCITIC FLUID ANALYSIS IN CIRRHOTIC AND MALIGNANCY-RELATED ASCITES
    ALCALDE, M
    GARCIADIAZ, M
    DESANDE, F
    SANCHEZ, P
    DIAZ, P
    PECELLIN, I
    DONOSO, M
    GASTROENTEROLOGY, 1995, 108 (04) : A1025 - A1025
  • [22] EDITORIAL - MALIGNANCY-RELATED ASCITES AND ASCITIC FLUID HUMORAL TESTS OF MALIGNANCY
    RUNYON, BA
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 18 (02) : 94 - 98
  • [23] Malignancy-related mortality following kidney transplantation is common
    Farrugia, Daniela
    Mahboob, Sophia
    Cheshire, James
    Begaj, Irena
    Khosla, Sajan
    Ray, Daniel
    Sharif, Adnan
    KIDNEY INTERNATIONAL, 2014, 85 (06) : 1395 - 1403
  • [24] Emergent Management of Malignancy-Related Acute Airway Obstruction
    Theodore, Pierre R.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2009, 27 (02) : 231 - +
  • [25] A survey of practice in management of malignancy-related ascites in Japan
    Kanai, Yoshiaki
    Ishiki, Hiroto
    Maeda, Isseki
    Iwase, Satoru
    PLOS ONE, 2019, 14 (08):
  • [26] Characterizing the expression of malignancy-related microRNAs in dysplastic nevi
    Mattessich, Sarah
    Belanger, Matthew
    Wu, Rong
    Dadras, Soheil
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB71 - AB71
  • [27] Spontaneous bacterial peritonitis complicating malignancy-related ascites
    Bac, DJ
    DeMarie, S
    VanBlankenstein, M
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (01) : 131 - 132
  • [28] Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy
    Guay, DRP
    PHARMACOTHERAPY, 2006, 26 (05): : 655 - 673
  • [29] Denosumab treatment of hypercalcemia of malignancy (HCM) in patients not responding to bisphosphonate therapy
    Leboulleux, S.
    Hu, M.
    Glezerman, I.
    Gucalp, R.
    Misiorowski, W.
    Jaccard, A.
    Tonini, G.
    Ying, W.
    Braun, A.
    Jain, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S287 - S287
  • [30] LEVELS OF PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) IN HYPERCALCEMIA OF MALIGNANCY ARE NOT LOWERED BY TREATMENT WITH THE BISPHOSPHONATE BM 21.0955
    BLIND, E
    RAUE, F
    MEINEL, T
    WUSTER, C
    ZIEGLER, R
    HORMONE AND METABOLIC RESEARCH, 1993, 25 (01) : 40 - 44
12345